This peptide is an epitope of carcinoembryonic antigen and is recognized by T cells in the immune system; it may have potential in the development of vaccines or targeting therapies. This analog differs slightly from the original peptide, with a N610D change.
| Purity | ≥95% |
|---|---|
| Formula | C43H68N10O15 |
| Formula Wt. | 965.08 |
| Synonym | CEA |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet | C1601 Info Sheet PDF |
|---|
Hou Y, Kavanagh B, Fong L. Distinct CD8+ T cell repertoires primed with agonist and native peptides derived from a tumor-associated antigen. J Immunol. 2008 Feb 1;180(3):1526-34. PMID: 18209048.
Tosi D, Valenti R, Cova A, et al. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens. J Immunol. 2004 May 1;172(9):5363-70. PMID: 15100276.
